These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 14604287

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinicopathological analysis of allogeneic hematopoietic stem cell transplantation-related membranous glomerulonephritis.
    Hiramatsu R, Ubara Y, Sawa N, Hasegawa E, Kawada M, Imafuku A, Sumida K, Mise K, Yamanouchi M, Ueno T, Sekine A, Hayami N, Suwabe T, Hoshino J, Takaichi K, Ohashi K, Fujii T, Wake A, Taniguchi S.
    Hum Pathol; 2016 Apr; 50():187-94. PubMed ID: 26997455
    [Abstract] [Full Text] [Related]

  • 3. [Complete remission of repeated recurrent membranous nephropathy after non-myeloablative allogeneic peripheral blood stem cell transplantation].
    Matsuura T, Hiramoto N, Iwasa T, Shoji M, Ohashi K.
    Nihon Jinzo Gakkai Shi; 2013 Apr; 55(7):1327-34. PubMed ID: 24288970
    [Abstract] [Full Text] [Related]

  • 4. A boy with membranous nephropathy after allogeneic bone marrow transplantation.
    Motoyama O, Uchino Y, Tokuyama M, Iitaka K, Ohara A.
    Clin Exp Nephrol; 2009 Oct; 13(5):508-511. PubMed ID: 19424655
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nephrotic syndrome in a bone marrow transplant recipient with chronic graft-versus-host disease.
    Sato N, Kishi K, Yagisawa K, Kasama J, Karasawa R, Shimada H, Nishi S, Ueno M, Ito K, Koike T.
    Bone Marrow Transplant; 1995 Aug; 16(2):303-5. PubMed ID: 7581152
    [Abstract] [Full Text] [Related]

  • 8. Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome.
    Depil S, Deconinck E, Milpied N, Sutton L, Witz F, Jouet JP, Damaj G, Yakoub-Agha I, Société Française de Greffe de Moelle et Thérapie cellulaire.
    Bone Marrow Transplant; 2004 Mar; 33(5):531-4. PubMed ID: 14716345
    [Abstract] [Full Text] [Related]

  • 9. [Extramembranous glomerulonephritis and myelodysplastic syndrome].
    Doukkali O, Tarrass F, Medkouri G, Fatihi E, Ramdani B, Zaid D, Azzouzi S, Sqalli S.
    Nephrologie; 2004 Mar; 25(2):59-61. PubMed ID: 15119222
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment with candesartan combined with angiotensin-converting enzyme inhibitor for immunosuppressive treatment-resistant nephrotic syndrome after allogeneic stem cell transplantation.
    Osugi Y, Yamada H, Hosoi G, Noma H, Ikemiya M, Ishii T, Sako M.
    Int J Hematol; 2006 Jun; 83(5):454-8. PubMed ID: 16787879
    [Abstract] [Full Text] [Related]

  • 13. Management of Myelodysplastic Syndrome Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: A Study by the French Society of Bone Marrow Transplantation and Cell Therapies.
    Guièze R, Damaj G, Pereira B, Robin M, Chevallier P, Michallet M, Vigouroux S, Beguin Y, Blaise D, El Cheikh J, Roos-Weil D, Thiebaut A, Rohrlich PS, Huynh A, Cornillon J, Contentin N, Suarez F, Lioure B, Mohty M, Maillard N, Clement L, François S, Guillerm G, Yakoub-Agha I.
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):240-247. PubMed ID: 26256942
    [Abstract] [Full Text] [Related]

  • 14. Interferon-α: A Potentially Effective Treatment for Minimal Residual Disease in Acute Leukemia/Myelodysplastic Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.
    Mo XD, Zhang XH, Xu LP, Wang Y, Yan CH, Chen H, Chen YH, Han W, Wang FR, Wang JZ, Liu KY, Huang XJ.
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1939-47. PubMed ID: 26116088
    [Abstract] [Full Text] [Related]

  • 15. Donor lymphocyte infusion for a patient with relapsing myelodysplastic syndrome after allogeneic bone marrow transplantation.
    Bressoud A, Chapuis B, Roux E, Cabrol C, Jeannet M, Roosnek E, Helg C.
    Blood; 1996 Sep 01; 88(5):1902-3. PubMed ID: 8781456
    [No Abstract] [Full Text] [Related]

  • 16. De novo postallogeneic hematopoietic stem cell transplant membranous nephropathy.
    Numata A, Morishita Y, Mori M, Saito O, Takemoto F, Ando Y, Muto S, Yumura W, Kusano E.
    Exp Clin Transplant; 2013 Feb 01; 11(1):75-8. PubMed ID: 22809119
    [Abstract] [Full Text] [Related]

  • 17. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q, Li H, Xie X, Qu F, Li X, Chen J.
    Ren Fail; 2017 Nov 01; 39(1):512-518. PubMed ID: 28562168
    [Abstract] [Full Text] [Related]

  • 18. Chronic graft versus host disease and nephrotic syndrome.
    Barbouch S, Gaied H, Abdelghani KB, Goucha R, Lakhal A, Torjemen L, Hamida FB, Abderrahim E, Maiz HB, HafedhHedri, Adel K.
    Saudi J Kidney Dis Transpl; 2014 Sep 01; 25(5):1062-4. PubMed ID: 25193909
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.